Consolidated Condensed Balance Sheets - USD ($) $ in Millions	Sep. 30, 2016	Dec. 31, 2015
Current Assets
Cash and cash equivalents	$ 3,489.0	$ 3,666.4
Short-term investments	737.8	785.4
Accounts receivable, net of allowances of $44.7 (2016) and $44.3 (2015)	3,848.5	3,513.0
Other receivables	672.9	558.6
Inventories	3,881.2	3,445.8
Prepaid expenses and other	756.5	604.4
Total current assets	13,385.9	12,573.6
Other Assets
Investments	5,027.0	3,646.6
Goodwill	4,007.7	4,039.9
Other intangibles, net	4,638.5	5,034.8
Sundry	2,279.3	2,220.5
Total other assets	15,952.5	14,941.8
Property and Equipment
Land, buildings, equipment, and construction in progress	17,237.8	16,660.9
Accumulated depreciation	(8,985.9)	(8,607.4)
Property and equipment, net	8,251.9	8,053.5
Total assets	37,590.3	35,568.9
Current Liabilities
Short-term borrowings and current maturities of long-term debt	641.5	6.1
Accounts payable	1,161.2	1,338.2
Employee compensation	738.5	967.0
Sales rebates and discounts	3,547.5	2,560.1
Dividends payable	0.0	539.0
Income taxes payable	183.0	358.9
Other current liabilities	2,001.1	2,460.3
Total current liabilities	8,272.8	8,229.6
Other Liabilities
Long-term debt	8,707.3	7,972.4
Accrued retirement benefits	2,077.8	2,160.3
Long-term income taxes payable	805.6	868.9
Other noncurrent liabilities	2,111.0	1,747.4
Total other liabilities	13,701.7	12,749.0
Eli Lilly and Company Shareholders' Equity
Common stock	690.4	691.3
Additional paid-in capital	5,648.6	5,552.1
Retained earnings	16,601.6	16,011.8
Employee benefit trust	(3,013.2)	(3,013.2)
Accumulated other comprehensive loss	(4,257.7)	(4,580.7)
Cost of common stock in treasury	(80.5)	(90.0)
Total Eli Lilly and Company shareholders' equity	15,589.2	14,571.3
Noncontrolling interests	26.6	19.0
Total equity	15,615.8	14,590.3
Total liabilities and equity	$ 37,590.3	$ 35,568.9